CDC25A and B dual-specificity phosphatase inhibitors: potential agents for cancer therapy.
about
CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycleGrowth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G1 Arrest/S Phase Delay and Inhibition of Apoptosis During Chemotherapy in Bone MarrowThe role of Cdc25A in the regulation of cell proliferation and apoptosisCancer models in Caenorhabditis elegans.Phosphotyrosine Substrate Sequence Motifs for Dual Specificity PhosphatasesCDC25 Inhibition in Acute Myeloid Leukemia-A Study of Patient Heterogeneity and the Effects of Different Inhibitors.MiR-210 disturbs mitotic progression through regulating a group of mitosis-related genesInhibitors of Cdc25 phosphatases as anticancer agents: a patent review.Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia--the possibility to target several kinases through inhibition of the various CDC25 isoforms.Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication.Identification of the quinolinedione inhibitor binding site in Cdc25 phosphatase B through docking and molecular dynamics simulations.Conformational flexibility of the complete catalytic domain of Cdc25B phosphatases.Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases.Therapeutic target discovery using Boolean network attractors: improvements of kali.
P2860
Q24622357-CADEF954-E7A9-4F75-8B44-1E07B3083DFAQ27853382-60242701-31A1-4073-9F8C-C74DFC1DBF34Q28611420-B115E0CD-73C6-4D21-993C-C8A50D839D75Q33903791-73A7BDB0-0D77-4A76-A9CD-7CAD0847F5DAQ35753812-6512C67A-E3AF-414F-B1B3-6BE5AF0DA6B4Q36305952-A535ECE4-C35E-4E71-A47D-55E1E25E3793Q36668837-E5DCD241-822D-40CC-9AA7-C5D4B6CEBC9AQ37694564-A3BB3AA6-622B-4ACF-91C8-D08F5D5D5F1EQ38268221-9EDD8EFB-16C9-4457-B016-6FAECDFCAC24Q38401664-EED8D9A5-1614-4606-9EE1-624077DB99E3Q41921115-D31CDD9A-67DF-466E-93B5-1934AD432559Q48294286-4C3EA04C-DE22-4955-9AEA-91DF253CB9F6Q48959549-BB883CA6-8A95-40E3-88BB-81E07D48E70DQ52363579-B170B3D4-4244-4755-BEE6-466400D5B767
P2860
CDC25A and B dual-specificity phosphatase inhibitors: potential agents for cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CDC25A and B dual-specificity ...... ial agents for cancer therapy.
@en
CDC25A and B dual-specificity ...... ial agents for cancer therapy.
@nl
type
label
CDC25A and B dual-specificity ...... ial agents for cancer therapy.
@en
CDC25A and B dual-specificity ...... ial agents for cancer therapy.
@nl
prefLabel
CDC25A and B dual-specificity ...... ial agents for cancer therapy.
@en
CDC25A and B dual-specificity ...... ial agents for cancer therapy.
@nl
P50
P1476
CDC25A and B dual-specificity phosphatase inhibitors: potential agents for cancer therapy
@en
P2093
Carmen Di Giovanni
P304
P356
10.2174/092986709788186084
P577
2009-01-01T00:00:00Z